Header Logo

Connection

Yeyi Zhu to Disease Progression

This is a "connection" page, showing publications Yeyi Zhu has written about Disease Progression.
Connection Strength

0.163
  1. Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice. Drug Des Devel Ther. 2019; 13:3657-3667.
    View in: PubMed
    Score: 0.163

© 2024 Kaiser Permanente